CHRISTINE CARRERO: Open Payments
NPI 1760116685 · NORTH VENICE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$838 in 41 payments from 18 companies in 2025. Trend: 2023 $248 · 2024 $1,241 · 2025 $838
Food & beverage: $838
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $231 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $102 |
| Collegium Pharmaceutical, Inc. | 4 | $80 |
| Neurocrine BioSciences, Inc. | 3 | $54 |
| ARGENX US, INC. | 2 | $54 |
| UCB, Inc. | 2 | $50 |
| Boston Scientific Corporation | 2 | $50 |
| CSL Behring | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| ACADIA Pharmaceuticals Inc | 1 | $23 |
Products named: QULIPTA, HYQVIA, UBRELVY, INGREZZA, Intracept, XTAMPZA, Belbuca, Zilbrysq.
Industry payments across FL — which companies pay providers there.
